“Necklace” fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy
- 16 December 2008
- journal article
- research article
- Published by Springer Nature in Acta Neuropathologica
- Vol. 117 (3) , 283-291
Abstract
Mutations in the gene encoding the phosphoinositide phosphatase myotubularin 1 protein (MTM1) are usually associated with severe neonatal X-linked myotubular myopathy (XLMTM). However, mutations in MTM1 have also been recognized as the underlying cause of “atypical” forms of XLMTM in newborn boys, female infants, female manifesting carriers and adult men. We reviewed systematically the biopsies of a cohort of patients with an unclassified form of centronuclear myopathy (CNM) and identified four patients presenting a peculiar histological alteration in some muscle fibers that resembled a necklace (“necklace fibers”). We analyzed further the clinical and morphological features and performed a screening of the genes involved in CNM. Muscle biopsies in all four patients demonstrated 4–20% of fibers with internalized nuclei aligned in a basophilic ring (necklace) at 3 μm beneath the sarcolemma. Ultrastructurally, such necklaces consisted of myofibrils of smaller diameter, in oblique orientation, surrounded by mitochondria, sarcoplasmic reticulum and glycogen granules. In the four patients (three women and one man), myopathy developed in early childhood but was slowly progressive. All had mutations in the MTM1 gene. Two mutations have previously been reported (p.E404K and p.R241Q), while two are novel; a c.205_206delinsAACT frameshift change in exon 4 and a c.1234A>G mutation in exon 11 leading to an abnormal splicing and the deletion of nine amino acids in the catalytic domain of MTM1. Necklace fibers were seen neither in DNM2- or BIN1-related CNM nor in males with classical XLMTM. The presence of necklace fibers is useful as a marker to direct genetic analysis to MTM1 in CNM.Keywords
This publication has 31 references indexed in Scilit:
- A NEW CENTRONUCLEAR MYOPATHY PHENOTYPE DUE TO A NOVEL DYNAMIN 2 MUTATIONNeurology, 2009
- AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasisHuman Molecular Genetics, 2008
- Multiple disease‐linked myotubularin mutations cause NFL assembly defects in cultured cells and disrupt myotubularin dimerizationJournal of Neurochemistry, 2007
- Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onsetAnnals of Neurology, 2007
- Characterization of the muscle involvement in dynamin 2-related centronuclear myopathyBrain, 2006
- Muscle biopsy without centrally located nuclei in a male child with mild X-linked myotubular myopathyDevelopmental Medicine & Child Neurology, 2005
- Mutations in dynamin 2 cause dominant centronuclear myopathyNature Genetics, 2005
- Myopathy with skeletal asymmetry and hemidiaphragm elevation is caused by myotubularin mutationsNeurology, 2005
- The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in miceProceedings of the National Academy of Sciences, 2002
- Characterization of mutations in fifty North American patients with X-linked myotubular myopathyHuman Mutation, 2002